{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:53:36Z","timestamp":1768557216114,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008799","name":"Gilead Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.atherosclerosis.2024.117457","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T10:00:17Z","timestamp":1705831217000},"page":"117457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Elevated plasma apolipoprotein E levels in people living with HIV: Associations with biomarkers and HIV-specific risk factors"],"prefix":"10.1016","volume":"390","author":[{"given":"Anne Marie","family":"Reimer Jensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gelpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas D.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Benfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoaib","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-7455","authenticated-orcid":false,"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.117457_bib1","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","author":"Mahley","year":"2019"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117457_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/499280","article-title":"The receptor\u2010binding region of human apolipoprotein E has direct anti\u2010infective activity","volume":"193","author":"Dobson","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"49","key":"10.1016\/j.atherosclerosis.2024.117457_bib3","doi-asserted-by":"crossref","first-page":"48529","DOI":"10.1074\/jbc.M306923200","article-title":"APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response","volume":"278","author":"Lynch","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117457_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-2275(20)32409-3","article-title":"Altered immune responses in apolipoprotein E-deficient mice","volume":"41","author":"Laskowitz","year":"2000","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117457_bib5","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0021-9150(99)00501-8","article-title":"Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project","volume":"152","author":"Schiele","year":"2000","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117457_bib6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/clinchem\/44.5.957","article-title":"Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study","volume":"44","author":"Vincent-Viry","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.117457_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2015.12.038","article-title":"Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population","volume":"246","author":"Rasmussen","year":"2016","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117457_bib8","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1371\/journal.pmed.0030176","article-title":"ApoE plasma levels and risk of cardiovascular mortality in old age","volume":"3","author":"Mooijaart","year":"2006","journal-title":"PLoS Med."},{"issue":"33","key":"10.1016\/j.atherosclerosis.2024.117457_bib9","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/eurheartj\/ehz402","article-title":"Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort","volume":"40","author":"Rasmussen","year":"2019","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117457_bib10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117457_bib11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cid\/ciy146","article-title":"Higher risk of abdominal obesity, elevated low-density lipoprotein cholesterol, and hypertriglyceridemia, but not of hypertension, in people living with human immunodeficiency virus (HIV): results from the Copenhagen comorbidity in HIV infection study","volume":"67","author":"Gelpi","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117457_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/hiv.12843","article-title":"Rate of dyslipidemia higher among women living with HIV: a comparison of metabolic and cardiovascular health in a cohort to study aging in HIV","volume":"21","author":"Russell","year":"2020","journal-title":"HIV Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117457_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1210\/jcem.86.1.7164","article-title":"Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy","volume":"86","author":"Bonnet","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117457_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/omi.2011.0004","article-title":"Investigation of plasma biomarkers in HIV-1\/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics","volume":"15","author":"Shetty","year":"2011","journal-title":"OMICS"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2024.117457_bib15","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1073\/pnas.0803526105","article-title":"Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro , and the APOE \u03b54\/\u03b54 genotype accelerates HIV disease progression","volume":"105","author":"Burt","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117457_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007372","article-title":"Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages","volume":"14","author":"Siddiqui","year":"2018","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117457_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1186\/s12879-016-2026-9","article-title":"Copenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark","volume":"16","author":"Ronit","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117457_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0000000000002119","article-title":"Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors","volume":"33","author":"Gelpi","year":"2019","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117457_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.24326","article-title":"Plasma levels of apolipoprotein E and risk of dementia in the general population","volume":"77","author":"Rasmussen","year":"2015","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117457_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117457_bib21","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"International society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"Supplement_1","key":"10.1016\/j.atherosclerosis.2024.117457_bib22","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of Care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117457_bib23","first-page":"9","article-title":"Appendix A: AIDS-defining conditions","volume":"57","year":"2008","journal-title":"MMWR (Morb. Mortal. Wkly. Rep.)"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117457_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117457_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-M\u00f8ller","year":"2003","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117457_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11904-016-0321-0","article-title":"Lipid abnormalities and inflammation in HIV infection","volume":"13","author":"Funderburg","year":"2016","journal-title":"Curr. HIV AIDS Rep."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117457_bib27","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/381783","article-title":"Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?","volume":"189","author":"Fontas","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117457_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1473-3099(13)70271-8","article-title":"Metabolic disease in HIV infection","volume":"13","author":"Lake","year":"2013","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117457_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/135965350601100310","article-title":"Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy","volume":"11","author":"Bard","year":"2006","journal-title":"Antivir. Ther."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117457_bib30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/QAD.0b013e3283352ed5","article-title":"Change to atazanavir\/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy","volume":"24","author":"Murphy","year":"2010","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117457_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jmv.23543","article-title":"Improved metabolic profile after switch to darunavir\/ritonavir in HIV positive patients previously on protease inhibitor therapy","volume":"85","author":"Ucciferri","year":"2013","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117457_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAI.0b013e31828ace69","article-title":"Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir\/emtricitabine in treatment-naive HIV-1\u2013Infected patients","volume":"63","author":"Rockstroh","year":"2013","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"9868","key":"10.1016\/j.atherosclerosis.2024.117457_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(12)61853-4","article-title":"Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study","volume":"381","author":"Raffi","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117457_bib34","first-page":"3734","article-title":"Abnormalities of apolipoprotein E in the acquired immunodeficiency Syndrome 1","volume":"82","author":"Grunfeld","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117457_bib35","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/QAD.0000000000000739","article-title":"Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration","volume":"29","author":"Maisa","year":"2015","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2024.117457_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/aid.2014.0239","article-title":"Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens","volume":"31","author":"Munger","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024000170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:28:48Z","timestamp":1762187328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024000170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"alternative-id":["S0021915024000170"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117457","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated plasma apolipoprotein E levels in people living with HIV: Associations with biomarkers and HIV-specific risk factors","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117457"}}